Microscaled proteogenomic methods for precision oncologyShankha Satpathy, Matthew J. Ellis, Eric J. Jaehnig et al.|Nature Communications|2020Cited by 122
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort studyRenée Schmitz, Marjanka K. Schmidt, Alexandra W. van den Belt‐Dusebout et al.|BMJ|2023Cited by 44
Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspiratesDaniel Y. Joh, Ashutosh Chilkoti, Jacob T. Heggestad et al.|npj Breast Cancer|2021Cited by 17
Microscaled Proteogenomic Methods for Precision OncologyShankha Satpathy, Matthew J. Ellis, Eric J. Jaehnig et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 12
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkersEric J. Jaehnig, Meenakshi Anurag, Aranzazu Fernandez-Martinez et al.|Cell Reports Medicine|2025Cited by 3